Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 743-750

  Tufail, Rozina ^a   Jorda, Mercy ^a   Zhao, Wei ^a   Reis, Isildinha ^a   Nawaz, Zafar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen receptor; Progesterone receptor; Yes associated protein

Indexed keywords

ESTROGEN RECEPTOR; MOLECULAR MARKER; PHOSPHOPROTEIN; PROGESTERONE RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TISSUE MICROARRAY; TRANSACTIVATION;

BREAST; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TRANSCRIPTION FACTORS;

EID: 84856212176     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1435-0     Document Type: Article

References (27)

1. M Sudol 1994 Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product Oncogene 9 2145 2152 8035999 1:CAS:528:DyaK2cXlvFOgsL8%3D
2. M Sudol CC Recinos J Abraczinskas J Humbert A Farooq 2005 WW or WoW: the WW domains in a union of bliss IUBMB Life 57 773 778 16393779 10.1080/15216540500389039 1:CAS:528:DC%2BD2MXhtlGhtbjI
3. M Sudol K Sliwa T Russo 2001 Functions of WW domains in the nucleus FEBS Lett 490 190 195 11223034 10.1016/S0014-5793(01)02122-6 1:CAS:528: DC%2BD3MXht1Ort70%3D
4. R Yagi LF Chen K Shigesada Y Murakami Y Ito 1999 A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator EMBO J 18 2551 2562 10228168 10.1093/emboj/18.9.2551 1:CAS:528:DyaK1MXjtlKhsLo%3D
5. M Sudol T Hunter 2000 NeW wrinkles for an old domain Cell 103 1001 1004 11163176 10.1016/S0092-8674(00)00203-8 1:CAS:528:DC%2BD3MXit1WrsQ%3D%3D
6. S Basu NF Totty MS Irwin M Sudol J Downward 2003 Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis Mol Cell 11 11 23 12535517 10.1016/S1097-2765(02) 00776-1 1:CAS:528:DC%2BD3sXhtFahu74%3D
7. M Overholtzer J Zhang GA Smolen, et al. 2006 Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Proc Natl Acad Sci USA 103 12405 12410 16894141 10.1073/pnas.0605579103 1:CAS:528: DC%2BD28Xos1Kls74%3D
8. AA Steinhardt MF Gayyed AP Klein, et al. 2008 Expression of Yes-associated protein in common solid tumors Hum Pathol 39 1582 1589 18703216 10.1016/j.humpath.2008.04.012 1:CAS:528:DC%2BD1cXht1Kns7vK
9. S Strano E Munarriz M Rossi, et al. 2001 Physical interaction with Yes-associated protein enhances p73 transcriptional activity J Biol Chem 276 15164 15173 11278685 10.1074/jbc.M010484200 1:CAS:528:DC%2BD3MXjs1Orsbc%3D
10. B Zhao X Ye JD Yu, et al. 2008 TEAD mediates YAP-dependent gene induction and growth control Genes Dev 22 1962 1971 18579750 10.1101/gad.1664408 1:CAS:528:DC%2BD1cXovFWlsb8%3D
11. R Ehsanian M Brown H Lu, et al. 2010 YAP dysregulation by phosphorylation or DeltaNp63-mediated gene repression promotes proliferation, survival and migration in head and neck cancer subsets Oncogene 29 6160 6171 20729916 10.1038/onc.2010.339 1:CAS:528:DC%2BC3cXhtVGgtbzL
12. M Yuan V Tomlinson R Lara, et al. 2008 Yes-associated protein (YAP) functions as a tumor suppressor in breast Cell Death Differ 15 1752 1759 18617895 10.1038/cdd.2008.108 1:CAS:528:DC%2BD1cXht1aru7zF
13. DC Allred Y Wu S Mao, et al. 2008 Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution Clin Cancer Res 14 370 378 18223211 10.1158/1078-0432.CCR-07-1127 1:CAS:528:DC%2BD1cXhtVKitrs%3D
14. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 57 70 10647931 10.1016/S0092-8674(00)81683-9 1:CAS:528:DC%2BD3cXks1CktA%3D%3D
15. K Horwitz C Clarke 1998 Estrogens and progestins in mammary development and neoplasia. Introduction J Mammary Gland Biol Neoplasia 3 1 2 10819499 10.1023/A:1018716732135 1:STN:280:DC%2BD3c3nslOrtA%3D%3D
16. AG Naccarato P Viacava S Vignati, et al. 2000 Bio-morphological events in the development of the human female mammary gland from fetal age to puberty Virchows Arch 436 431 438 10881736 10.1007/s004280050470 1:STN:280: DC%2BD3czjvVKntw%3D%3D
17. BB Bryan SJ Schnitt LC Collins 2006 Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer Mod Pathol 19 617 621 16528377 10.1038/modpathol.3800570 1:CAS:528: DC%2BD28Xjs1agtbg%3D
18. CC Benz GK Scott JC Sarup, et al. 1992 Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu Breast Cancer Res Treat 24 85 95 8095168 10.1007/BF01961241 1:STN:280: DyaK3s7osVentQ%3D%3D
19. GM Clark WL McGuire 1988 Steroid receptors and other prognostic factors in primary breast cancer Semin Oncol 15 20 25 3285482 1:STN:280: DyaL1c3hvVOnsw%3D%3D
20. RB Clarke E Anderson A Howell 2004 Steroid receptors in human breast cancer Trends Endocrinol Metab 15 316 323 15350603 10.1016/j.tem.2004.07.004 1:CAS:528:DC%2BD2cXntlSgsLY%3D
21. TC Putti DM El-Rehim EA Rakha, et al. 2005 Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis Mod Pathol 18 26 35 15332092 10.1038/modpathol.3800255 1:CAS:528:DC%2BD2MXivVWj
22. SC Dhananjayan S Ramamoorthy OY Khan, et al. 2006 WW domain binding protein-2, an E6-associated protein interacting protein, acts as a coactivator of estrogen and progesterone receptors Mol Endocrinol 20 2343 2354 16772533 10.1210/me.2005-0533 1:CAS:528:DC%2BD28XhtVOht7vL
23. B Zhao X Wei W Li, et al. 2007 Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev 21 2747 2761 17974916 10.1101/gad.1602907 1:CAS:528:DC%2BD2sXhtlSitLrK
24. P Kastner A Krust B Turcotte, et al. 1990 Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B EMBO J 9 1603 1614 2328727 1:CAS:528:DyaK3cXmtVGkuro%3D
25. OY Khan G Fu A Ismail, et al. 2006 Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland Mol Endocrinol 20 544 559 16254014 10.1210/me.2005-0110 1:CAS:528:DC%2BD28Xit1SnsL0%3D
26. NJ McKenna J Xu Z Nawaz SY Tsai MJ Tsai BW O'Malley 1999 Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions J Steroid Biochem Mol Biol 69 3 12 10418975 10.1016/S0960-0760(98)00144-7 1:CAS:528:DyaK1MXktlOmtrc%3D
27. E Bertini T Oka M Sudol S Strano G Blandino 2009 YAP: at the crossroad between transformation and tumor suppression Cell Cycle 8 49 57 19106601 10.4161/cc.8.1.7259 1:CAS:528:DC%2BD1MXlvFSqtro%3D